140 related articles for article (PubMed ID: 7768199)
21. Cardiac and hemodynamic effects of intravenous R80122, a new phosphodiesterase III inhibitor, in a canine model of myocardial ischemia and heart failure.
Van de Water A; Xhonneux R; Reneman RS; Janssen PA
J Cardiovasc Pharmacol; 1992 Jul; 20(1):18-24. PubMed ID: 1383627
[TBL] [Abstract][Full Text] [Related]
22. Positive inotropy contributes to the hemodynamic mechanism of action of flosequinan (BTS 49465) in the intact dog.
Greenberg S; Touhey B
J Cardiovasc Pharmacol; 1990 Jun; 15(6):900-10. PubMed ID: 1694912
[TBL] [Abstract][Full Text] [Related]
23. Acute and subacute hemodynamic effects of enalaprilat, milrinone and combination therapy in rats with chronic left ventricular dysfunction.
Emmert SE; Stabilito II; Sweet CS
Clin Exp Hypertens A; 1987; 9(2-3):297-306. PubMed ID: 3038390
[TBL] [Abstract][Full Text] [Related]
24. Influence of acidosis on cardiotonic effects of milrinone.
Tanaka M; Ishikawa T; Nishikawa T; Goto K; Sato S
Anesthesiology; 1998 Mar; 88(3):725-34. PubMed ID: 9523817
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
[TBL] [Abstract][Full Text] [Related]
26. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.
Collis MG; Keddie JR; Rouse W
Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the vasodilator vs inotropic effect of milrinone using an animal model of left ventricular failure: reversal of disopyramide depression of the myocardium with milrinone.
Goldberg E; Berdoff R; Spivack G; Haimowitz A; Tay S
Angiology; 1987 Sep; 38(9):657-62. PubMed ID: 3662108
[TBL] [Abstract][Full Text] [Related]
28. Positive inotropic effects of milrinone, sulmazole and AR-L100 on isolated normal and infarcted hearts of the rat.
Verrijk R; Vleeming W; van Rooij HH; Wemer J; Porsius AJ
Arch Int Pharmacodyn Ther; 1989; 297():7-17. PubMed ID: 2730243
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic profile of BM 14.478: a new positive inotropic and vasodilating agent.
Müller-Beckmann B; Sponer G; Strein K; Bartsch W
J Cardiovasc Pharmacol; 1988 Jan; 11(1):1-7. PubMed ID: 2450246
[TBL] [Abstract][Full Text] [Related]
30. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R
Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
Pagani ED; Dundore RL; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular effects of milrinone.
Colucci WS
Am Heart J; 1991 Jun; 121(6 Pt 2):1945-7. PubMed ID: 2035424
[TBL] [Abstract][Full Text] [Related]
33. Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside and nitroglycerin.
Arkonac BM; Kersten JR; Wynsen JC; Nijhawan N; Warltier DC
Pharmacology; 1996 Feb; 52(2):92-100. PubMed ID: 8851630
[TBL] [Abstract][Full Text] [Related]
34. Plasma elimination of milrinone in rats in relation to its hemodynamic effects.
Verrijk R; Vleeming W; van Rooij HH; Wemer J; Porsius AJ
J Pharm Sci; 1990 Mar; 79(3):236-9. PubMed ID: 2338634
[TBL] [Abstract][Full Text] [Related]
35. Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure.
Sonnenblick EH; Grose R; Strain J; Zelcer AA; LeJemtel TH
Circulation; 1986 Mar; 73(3 Pt 2):III162-7. PubMed ID: 3510772
[TBL] [Abstract][Full Text] [Related]
36. Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite.
Falotico R; Haertlein BJ; Lakas-Weiss CS; Salata JJ; Tobia AJ
J Cardiovasc Pharmacol; 1989 Sep; 14(3):412-8. PubMed ID: 2476620
[TBL] [Abstract][Full Text] [Related]
37. [Effects of amrinone on renal blood flow and cardiac function, in comparison with those of milrinone and olprinone, in anesthetized dog].
Fujishima K; Yamamoto A; Hachisu M
Nihon Yakurigaku Zasshi; 1998 Dec; 112(6):371-80. PubMed ID: 10202762
[TBL] [Abstract][Full Text] [Related]
38. Acute effects of intravenous milrinone in heart failure.
Rettig GF; Schieffer HJ
Eur Heart J; 1989 Aug; 10 Suppl C():39-43. PubMed ID: 2680496
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
Al-Wathiqui MH; Shimshak TM; Brooks HL; Preuss KC; Wynsen JC; Gross GJ; Warltier DC
Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877
[TBL] [Abstract][Full Text] [Related]
40. Milrinone: a positive inotropic vasodilator.
Colucci WS; Jaski BE; Fifer MA; Wright RF; Braunwald E
Trans Assoc Am Physicians; 1984; 97():124-33. PubMed ID: 6535335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
